Citation: | ZHUANG Xueming, WANG Shibo, YU Dawei, SHI Meiling, WANG Zhongxiang, XU Dongsheng, ZHANG Ye. Value of combined detection of antibacterial peptide LL-37 and procalcitonin in patients with septic shock[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 96-100. DOI: 10.7619/jcmp.20201396 |
[1] |
RUSSELL J A, RUSH B, BOYD J. Pathophysiology of septic shock[J]. Crit Care Clin, 2018, 34(1): 43-61. doi: 10.1016/j.ccc.2017.08.005
|
[2] |
CAHILL L A, JOUGHIN B A, KWON W Y, et al. Multiplexed plasma immune mediator signatures can differentiate sepsis from noninfective SIRS: American Surgical Association 2020 Annual Meeting Paper[J]. Ann Surg, 2020, 272(4): 604-610. doi: 10.1097/SLA.0000000000004379
|
[3] |
HASHEM H E, EL MASRY S A, MOKHTAR A M, et al. Valuable role of neutrophil CD64 and highly sensitive CRP biomarkers for diagnostic, monitoring, and prognostic evaluations of Sepsis patients in Neonatal ICUs[J]. Biomed Res Int, 2020, 11: 1-12. http://www.researchgate.net/publication/343539297_Valuable_Role_of_Neutrophil_CD64_and_Highly_Sensitive_CRP_Biomarkers_for_Diagnostic_Monitoring_and_Prognostic_Evaluations_of_Sepsis_Patients_in_Neonatal_ICUs/download
|
[4] |
RHODES A, EVANS L E, ALHAZZANI W, et al. Surviving Sepsis campaign: international guidelines for management of Sepsis and septic shock: 2016[J]. Crit Care Med, 2017, 45(3): 486-552. doi: 10.1097/CCM.0000000000002255
|
[5] |
QIN X, ZHU G, HUANG L, et al. LL-37 and its analog FF/CAP18 attenuate neutrophil migration in sepsis-induced acute lung injury[J]. J Cell Biochem, 2019, 120(4): 4863-4871. doi: 10.1002/jcb.27641
|
[6] |
HO J, HO J, ZHANG L, et al. Pathological role and diagnostic value of endogenous host defense peptides in adult and neonatal sepsis: a systematic review[J]. Shock, 2017, 47(6): 673-679. doi: 10.1097/SHK.0000000000000815
|
[7] |
SEYMOUR C W, LIU V X, IWASHYNA T J, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 762-774. doi: 10.1001/jama.2016.0288
|
[8] |
PAHAR B, MADONNA S, DAS A, et al. Immunomodulatory role of the antimicrobial LL-37 peptide in autoimmune diseases and viral infections[J]. Vaccines (Basel), 2020, 8(3): E517. doi: 10.3390/vaccines8030517
|
[9] |
BABIKIR I H, ABUGROUN E A, BILAL N E, et al. The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections[J]. BMC Infect Dis, 2018, 18(1): 17. doi: 10.1186/s12879-017-2901-z
|
[10] |
NAGAOKA I, TAMURA H, REICH J. Therapeutic potential of cathelicidin peptide LL-37, an antimicrobial agent, in a murine Sepsis model[J]. Int J Mol Sci, 2020, 21(17): E5973. doi: 10.3390/ijms21175973
|
[11] |
YANG B, GOOD D, MOSAIAB T, et al. Significance of LL-37 on immunomodulation and disease outcome[J]. Biomed Res Int, 2020, 2020: 8349712. http://www.hindawi.com/journals/bmri/2020/8349712/
|
[12] |
YAN C Y, LIU Y Z, XU Z H, et al. Comparison of antibacterial effect of cationic peptide LL-37 and cefalexin on Clinical Staphylococcus aureus-induced infection after femur fracture fixation[J]. Orthop Surg, 2020, 12(4): 1313-1318. doi: 10.1111/os.12754
|
[13] |
HU Z, MURAKAMI T, SUZUKI K, et al. Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice[J]. Int Immunol, 2016, 28(5): 245-253. doi: 10.1093/intimm/dxv113
|
[14] |
郭巍娜, 王春梅, 霍方捷, 等. 人抗菌肽LL-37对老年脓毒症患者预后的评估价值[J]. 中华危重病急救医学, 2018, 30(11): 1011-1016. doi: 10.3760/cma.j.issn.2095-4352.2018.11.001
|
[15] |
ZUO Y L, DANG R, PENG H Y, et al. LL-37 exacerbates local inflammation in Sepsis-induced acute lung injury by preventing mitochondrial DNA (mtDNA) degradation-induced autophagy[J]. Med Sci Monit, 2019, 25: 6193-9203. doi: 10.12659/MSM.915298
|
[16] |
SALAMAH M F, RAVISHANKAR D, KODJI X, et al. The endogenous antimicrobial cathelicidin LL-37 induces platelet activation and augments Thrombus formation[J]. Blood Adv, 2018, 2(21): 2973-2985. doi: 10.1182/bloodadvances.2018021758
|
[17] |
LE J, DAM Q, SCHWEIZER M, et al. Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37[J]. Eur J Clin Microbiol Infect Dis, 2016, 35(9): 1441-1447. doi: 10.1007/s10096-016-2682-0
|
[18] |
HOSODA H, NAKAMURA K, HU Z S, et al. Antimicrobial cathelicidin peptide LL-37 induces NET formation and suppresses the inflammatory response in a mouse septic model[J]. Mol Med Rep, 2017, 16(4): 5618-5626. doi: 10.3892/mmr.2017.7267
|
[19] |
王盛标, 李涛, 李云峰, 等. 4种评分系统对脓毒症患者预后的评估价值: 附311例回顾性分析[J]. 中华危重病急救医学, 2017, 29(2): 133-138.
|
[20] |
ZHU Y, XU L, COLLINS J J P, et al. Human umbilical cord mesenchymal stromal cells improve survival and bacterial clearance in neonatal Sepsis in rats[J]. Stem Cells Dev, 2017, 26(14): 1054-1064. doi: 10.1089/scd.2016.0329
|